Genomics

Areas of Interest

We are interested in study submissions involving:

• The potential clinical utilities of liquid biopsies and tumor tissue in both localized and advanced stage cancers.
• The relative potential clinical utility of identifying and following multiple versus single biomarkers by ctDNA and tumor tissue DNA analysis.
• Applications of ctDNA analysis and tumor tissue DNA analysis that demonstrate the potential to have a big impact in cancer treatment and management.
• Explore ctDNA as an indicator of minimum residual disease (MRD).
• Correlate ctDNA levels and mutations with tumor volume measured by radiographic imaging across all stages.

Out of Scope

We have little interest in study submissions involving:

• Studies that focus on cancer screening using circulating DNA
• Studies that are in the hematological malignancy space
• Strategies not incorporating Roche products

Platforms

We can support studies on the following systems:

• cobas z 480
• MagNA Pure
• AVENIO ctDNA & FFPET
• AVENIO Millisect